Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.
De Luca A, Cingolani A, Di Giambenedetto S, Trotta MP, Baldini F, Rizzo MG, Bertoli A, Liuzzi G, Narciso P, Murri R, Ammassari A, Perno CF, Antinori A. De Luca A, et al. Among authors: baldini f. J Infect Dis. 2003 Jun 15;187(12):1934-43. doi: 10.1086/375355. Epub 2003 May 22. J Infect Dis. 2003. PMID: 12792870 Clinical Trial.
The influence of hepatitis C virus coinfection on the risk of lipid abnormalities in a cohort of HIV-1-infected patients after initiation of highly active antiretroviral therapy.
Di Giambenedetto S, Baldini F, Cingolani A, Tamburrini E, Cauda R, De Luca A. Di Giambenedetto S, et al. Among authors: baldini f. J Acquir Immune Defic Syndr. 2004 May 1;36(1):641-2. doi: 10.1097/00126334-200405010-00015. J Acquir Immune Defic Syndr. 2004. PMID: 15097310 No abstract available.
Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy.
Giancola ML, Lorenzini P, Balestra P, Larussa D, Baldini F, Corpolongo A, Narciso P, Bellagamba R, Tozzi V, Antinori A. Giancola ML, et al. Among authors: baldini f. J Acquir Immune Defic Syndr. 2006 Mar;41(3):332-7. doi: 10.1097/01.qai.0000197077.64021.07. J Acquir Immune Defic Syndr. 2006. PMID: 16540934
Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
Giancola ML, Rizzi EB, Lorenzini P, Rovighi L, Baldini F, Schininà V, Larussa D, Bibbolino C, Antinori A. Giancola ML, et al. Among authors: baldini f. AIDS Res Hum Retroviruses. 2008 Feb;24(2):155-62. doi: 10.1089/aid.2006.0252. AIDS Res Hum Retroviruses. 2008. PMID: 18240958
Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders.
Giancola ML, Lorenzini P, Cingolani A, Baldini F, Bossolasco S, Bini T, Monno L, Picchi G, d'Arminio Monforte A, Cinque P, Tozzi V, Antinori A. Giancola ML, et al. Among authors: baldini f. AIDS Res Treat. 2012;2012:708456. doi: 10.1155/2012/708456. Epub 2012 Aug 26. AIDS Res Treat. 2012. PMID: 22957220 Free PMC article.
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.
Zaccarelli M, Lorenzini P, Tozzi V, Forbici F, Ceccherini-Silberstein F, Gori C, D'Arrigo R, Trotta MP, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of the HIV Genotype Resistance Test (GRT) at the National Institute for Infectious Diseases "Lazzaro Spallanzani". Zaccarelli M, et al. Infection. 2009 Jun;37(3):203-9. doi: 10.1007/s15010-008-8142-8. Epub 2009 Mar 9. Infection. 2009. PMID: 19274429
203 results